mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |